Health Condition 1: E785- Hyperlipidemia, unspecified
Conditions
Interventions
Intervention1: Dioscorea villosa in 50 millesimal potencies along with dietary management and exercises: Intervention is planned as
administering Dioscorea villosa in 50-millesimal potencies, as decid
16 doses to be marked on the vial
each dose of 5 ml to be taken after 10 uniformly forceful downward strokes to the vial in 45 ml normal water in a clean cup, to stir well, to take 5 ml of this liquid orally, and to
discard rest of th
dosage and repetition depending upon the individual requirement of the cases. All medicines will be procured from a Good Manufacturing Practice (GMP)-certified firm. Dietary advices in terms of low sa
each dose of 5 ml to be taken after 10 uniformly forceful downward
strokes to the vial in 45 ml
normal water in a clean cup, to stir well, to take 5 ml of this liquid orally, and to discard rest of th
dosage and repetition
depending upon the individual<
Sponsors
The Calcutta Homoeopathic Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age between 18 and 65 years 2. Patients of either sex 3. Newly diagnosed dyslipidemia patients not undergoing any therapy 4. Providing with written informed consent to participate in the trial
Exclusion criteria
Exclusion criteria: 1. Patients who are too sick for consultation 2. Diagnosed cases of systemic diseases, unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure 3. Pregnancy, puerperium, lactation 4. Substance abuse and/or dependence 5. Self-reported immune-compromised state 6. Undergoing homeopathic treatment for any other chronic disease within last 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood level of lowââ?¬â??density lipoprotein cholesterol (LDLc)Timepoint: Baseline, month 1, month 2, month 3 | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood level of triglycerides (TG), total cholesterol (TC), very low density lipoprotein cholesterol (VLDLc), and high density lipoprotein cholesterol (HDLc)Timepoint: Baseline, month 1, month 2, month 3 | — |
Countries
India
Contacts
Public ContactRajat Chattopadhyay
D N De Homoeopathic Medical College & Hospital
Outcome results
None listed